Why Men’s Health & ED Navigator?
ED as an Endothelial & Cardiovascular Sentinel
Operationalizes the fundamental principle that erectile dysfunction serves as an early vascular window into occult coronary artery disease, shifting management from symptomatic prescribing to comprehensive cardiovascular risk stratification.
AUA & Princeton IV Algorithmic Rigor
Integrates the validated IIEF-5 (SHIM) tool, nocturnal penile tumescence etiology discrimination, Princeton IV cardiac exercise capacity (≥4 METs) screening, and strict AUA two-morning testosterone diagnostic criteria into one workflow.
Safety-First Dual Pathway & EHR Generation
Prevents catastrophic nitrate contraindications, safeguards male fertility during hypogonadism management, harmonizes concurrent PDE5i and TRT titration, and generates structured, documentation-ready EHR consultation notes with patient education handouts.
Clinical Workflow: 4-Stage Architecture
Stage 1: Rapid Triage & Clinical Stratification
- IIEF-5 / SHIM Screening: Supports direct score entry or a guided 5-question clinical inventory to classify severity from Mild (17–21) to Severe (1–7) on an interactive spectrum bar.
- Etiology Discrimination: Evaluates symptom onset pattern (gradual vs. abrupt vs. variable) and nocturnal penile tumescence (NPT) presence to differentiate organic endothelial dysfunction from psychogenic performance anxiety.
- Princeton IV Cardiac Triage: Screens functional exercise capacity (≥4 METs benchmark, e.g., briskly climbing 2 flights of stairs) and flags absolute cardiac contraindications (unstable angina, recent MI, severe CHF, malignant arrhythmias).
Stage 2: Laboratory & Endocrine Evaluation
- AUA Hypogonadism Protocol: Enforces the mandatory confirmation standard of two separate fasting morning total testosterone draws (<300 ng/dL) drawn prior to 10:00 AM.
- Hypothalamic-Pituitary-Gonadal Axis: Evaluates LH and FSH concentrations to distinguish primary testicular failure from secondary (central) hypogonadism and triggers hyperprolactinemia workups.
- Fertility Preservation Safeguards: Identifies active desire for fertility to prevent iatrogenic azoospermia from exogenous TRT, routing eligible patients to alternative hypothalamic stimulation (SERMs or hCG).
Stage 3: Pharmacotherapy & Safety Harmonization
- PDE5 Inhibitor Optimization: Differentiates PRN dosing from once-daily regimens across sildenafil, tadalafil, and vardenafil, detailing proper absorption conditions (avoiding high-fat meals).
- Nitrate & sGC Stimulator Hard-Stops: Flags absolute contraindications with short-acting and long-acting nitrates (minimum 24-hr hold for sildenafil, 48-hr for tadalafil) and provides alpha-blocker spacing guidance.
- Synergistic Dual Pathway (TRT + PDE5i): Coordinates testosterone replacement therapy (upregulating nitric oxide synthase) alongside PDE5i therapy when hypogonadism and endothelial dysfunction coexist.
Stage 4: EHR Consultation Synthesis & Patient Handout
- Live Clinical Status HUD: Real-time heads-up display continuously synthesizes the SHIM stage, Princeton IV risk tier, hypogonadism status, and active dual-pathway candidacy.
- Automated Documentation: Compiles a complete, formatted EHR consultation note ready for point-of-care export to Epic, Cerner, or other clinical systems.
- Actionable Patient Handout: Generates plain-language counseling guides covering medication timing, sexual stimulation requirements, lifestyle modifications, and red-flag symptoms.
How to Use the Men’s Health & ED Navigator in Practice
- Capture Baseline Severity & Onset Dynamics: Record patient demographics and complete the IIEF-5/SHIM assessment (or input an existing score), then log the onset tempo and morning erection patterns to stratify organic versus psychogenic drivers.
- Assess Cardiac Safety via Princeton IV: Confirm the patient meets the ≥4 METs functional capacity threshold (e.g., climbing 2 flights of stairs without symptoms) and rule out active high-risk cardiovascular contraindications.
- Evaluate Fasting Morning Endocrine Labs: Enter two confirmed early-morning total testosterone draws alongside gonadotropins (LH/FSH) and document future fertility intentions to select appropriate hormonal therapy.
- Review the Live Clinical Status HUD: Cross-check the integrated summary card to verify nitrate absence, confirm cardiovascular safety clearance, and identify dual-pathway (TRT + PDE5i) eligibility at a glance.
- Export Clinical Note & Deliver Instructions: Proceed to the EHR tab to copy the structured medical consultation note into your electronic chart and print the customized counseling handout for the patient.
